Results 151 to 160 of about 163,152 (318)

Dobutamine administration: a proposal for a standardized approach

Intensive Care Medicine Experimental
Dobutamine is the most commonly used inotropic agent in critically ill patients with impaired cardiac contractility. However, its benefit–risk profile remains debated, and clear, structured guidance for its use is lacking.
Lorenzo Calabró, Filippo Annoni, Fabio Silvio Taccone   +2 more
doaj   +1 more source

Management of non-Cardiac Organ Failure in cardiogenic shock

American Heart Journal Plus
Cardiogenic shock (CS) is a syndrome of low cardiac output leading to systemic hypoperfusion. The mainstay of management involves optimizing preload, afterload, and contractility to restore central hemodynamics.
Chirag Mehta, Abraham Shin, Brian Osorio, Daniel DePolo, Irene Vargas, Emily Hao, Ali Khan, Sahas Chandragiri, Sandipan Shringi, Paige O. McLean Diaz, Nicholas S. Potter, Mark Godding, Athena Poppas, Rachna Kataria, Marwan Saad, Omar Hyder, Neel R. Sodha, J. Dawn Abbott, Saraschandra Vallabhajosyula   +18 more
doaj   +1 more source

A critical reappraisal of the carotid sinus and carotid bulb: Distinguishing neurohistological function from vascular geometry

The Anatomical Record, EarlyView.
This review redefines the carotid bulb (CB) as a variable geometric dilation shaped by hemodynamics and the carotid sinus (CS) as a conserved neurohistological baroreceptor field. Distinguishing these entities clarifies a century of anatomical confusion and links geometry, neurohistology, and clinical interpretation within a unified framework ...
Răzvan Costin Tudose, Nicolae Radu, Mugurel Constantin Rusu   +2 more
wiley   +1 more source

Percutaneous Transluminal Angioplasty for Low Cardiac Output Syndrome due to Superior vena cava Stenosis with Venous Return Anomaly, after Open Heart Surgery for Pacemaker Lead-Induced Endocarditis

, 2016
Mizuki Sumi, Koji Hashizume, Tsuneo Ariyoshi, Seiji Matsukuma, Shun Nakaji, Kiyoyuki Eishi   +5 more
openalex   +2 more sources

The relationship between pre-operative right ventricular longitudinal strain and low-cardiac-output syndrome after surgical aortic valve replacement. [PDF]

Front Cardiovasc Med, 2023
Zhang YJ, Chen H, Dong YL, Shang JN, Ruan LT, Yan Y, Song Y.   +6 more
europepmc   +1 more source

Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

Arthritis &Rheumatology, EarlyView.
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean, Carrie Richardson, Anthony J. Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Discontinuation of Intravenous Catecholamine by Oral Ivabradine in a Patient with Decompensated Heart Failure with Low Cardiac Output Syndrome

, 2021
Ryo Shibata, J Takahashi, Hiromi Sato, Munehisa Bekki, Kodai Shibao, HIDEYA SATO, Shoichiro Nohara, Akihiro Honda, Naoki Itaya, Hidetoshi Chibana, Yoshihiro Fukumoto   +10 more
openalex   +2 more sources

Essential embryology for the Canadian pathologists’ assistant

Anatomical Sciences Education, EarlyView.
Abstract Pathologists' assistants (PAs) are pivotal in healthcare, conducting autopsies and examining tissues under a pathologist's guidance. Embryology knowledge is crucial for PAs to accurately assess anomalies and identify pathologies. Yet, it is often overlooked in academic PA training programs.
Samantha H. Nacci, William Tsui, Fang‐I Lu, Avrum I. Gotlieb, Danielle C. Bentley   +4 more
wiley   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source